Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 011045
Company: MEDPOINTE PHARM HLC
Company: MEDPOINTE PHARM HLC
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
MILPREM-200 | ESTROGENS, CONJUGATED; MEPROBAMATE | 0.45MG;200MG | TABLET;ORAL | Discontinued | None | No | No |
MILPREM-400 | ESTROGENS, CONJUGATED; MEPROBAMATE | 0.45MG;400MG | TABLET;ORAL | Discontinued | None | No | No |